Related Experiment Video
Updated: Apr 5, 2026

10:46
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
11.2K
Multiple Sclerosis Mortality Rates in Canada, 1975-2009
Sharon A Warren1, Wonita Janzen1, Kenneth G Warren2
11Faculty of Rehabilitation Medicine,University of Alberta,Edmonton,Alberta,Canada.
Summary
Mortality rates from multiple sclerosis (MS) in Canada remained stable between 1975-2009, with a shift towards later age at death. Despite improved healthcare, MS patients still face higher mortality risks than the general population.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Examined multiple sclerosis (MS) mortality trends in Canada from 1975 to 2009.
- Investigated changes in age at death for MS patients compared to the general population.
- Assessed the overall decrease in MS mortality rates over the study period.
Purpose of the Study:
- To analyze the trends in multiple sclerosis (MS) mortality in Canada over a 35-year period.
- To determine if the age at death for MS patients has changed relative to the general population.
- To ascertain whether MS mortality rates have decreased over time.
Main Methods:
- Calculated age-standardized mortality rates per 100,000 population for MS and all causes.
- Utilized data from Statistics Canada, standardized to the 2006 population.
- Analyzed mortality rates across different age groups and genders over five-year intervals.
Main Results:
- The average annual Canadian MS mortality rate was 1.23/100,000 between 1975-2009, showing stable overall trends.
- MS mortality rates decreased in younger age groups (0-39) but increased in older groups (60+), while all-cause mortality decreased across all ages.
- Female MS mortality rates were consistently higher than male rates, with the highest MS mortality concentrated in the 50-69 age groups.
Conclusions:
- Multiple sclerosis (MS) mortality shows a shift towards later ages at death, potentially linked to improved healthcare.
- Despite this shift, MS patients experience higher mortality risks compared to the general population.
- The observed changes in age at death for MS do not correlate with a reduction in overall mortality rates.

